Pivotal Partners - Crunchbase Company Profile & Funding
Pivotal bioVenture Partners | LinkedIn
Pivotal Partners
Pivotal BioVenture Partners, an early investor in schizophrenia drug developer Karuna, vaccine maker Vaxcyte, raises second fund of $389 million - San Francisco Business Times
Procyon Partners Merges with Pivotal Planning Group | Wealth Management